Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-04-002448
Filing Date
2004-03-15
Accepted
2004-03-15 06:34:39
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS - FORM 10-K g86994e10vk.htm 10-K 1831380
3 EX-10.15 DIRECTIORS' DEFERRED COMPENSATION PLAN g86994exv10w15.txt EX-10.15 27312
4 EX-21.1 SUBSIDIARIES OF THE REGISTRANT g86994exv21w1.txt EX-21.1 1191
5 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP g86994exv23w1.txt EX-23.1 640
6 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g86994exv31w1.txt EX-31.1 3795
7 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g86994exv31w2.txt EX-31.2 3703
8 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g86994exv32w1.txt EX-32.1 1217
9 EX-32.2 SECTION 906 CERTFIFICATION OF THE CFO g86994exv32w2.txt EX-32.2 1104
  Complete submission text file 0000950144-04-002448.txt   1872865
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 04667626
SIC: 2834 Pharmaceutical Preparations